Skip to content

The Association Between Overweight and Oocyte Diameter in Women Undergoing Vitro Fertilization

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01672931
Enrollment
60
Registered
2012-08-27
Start date
2012-09-30
Completion date
2013-09-30
Last updated
2012-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Obesity

Brief summary

We believe that there is an association between BMI and oocyte diameter in women undergoing IVF treatments. We plan to measure the oocyte diameter in 2 groups of women undergoing IVF. One group will have BMI 20-25 and the other group will have BMI above 30.

Interventions

OTHEROocyte Measurement

Sponsors

Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* IVF treated patients * BMI between 20-25 or over 30

Exclusion criteria

* Everyone else

Design outcomes

Primary

MeasureTime frameDescription
Larger Size of Oocyte DiameterOne yearOocyte will be measured in women undergoing IVF treatment

Countries

Israel

Contacts

Primary ContactGai Shrem, MD
gai.shrem@gmail.com972-50-6793080

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026